药物总览提供了酪酸梭菌活菌(米雅利桑制药)Clostridium butyricum M588 (Miyarisan)相关药品信息, 涵盖了药品临床前,临床阶段,注册,上市等药品全生命周期研发数据, 通过表格与图表等形式多维度地帮助帮助用户筛选与查看
Clostridium butyricumCBM 588:这种丁酸梭菌菌株早在1963年就用作益生菌,用于一种名为Miyairisan的药物制剂中。它已经过安全性评估,不携带任何编码任何已知毒素或毒力因子的基因。 两项随机对照试验发现,该菌株可减少接受幽门螺杆菌根除治疗的患者的腹部症状和腹泻发生率的副作用。 另一项针对溃疡性结肠炎患者的安慰剂...
Clostridium butyricum MIYAIRI 588 (CBM 588) is a probiotic bacterium used in antidiarrheal medicine in Japan. A few studies analyzed the changes in gut microbiome in patients treated with antimicrobials based on metagenomics sequencing. However, the impact of CBM 588 on gut metabolic alterations has...
急性胰腺炎(AP)是一种常见的腹部炎症性疾病。仅次于胰腺炎症的肠道稳态受到干扰会也使病情加重。已知具有免疫调节作用的益生菌丁酸梭菌(C.butyricum)菌株可抑制肠道炎症。来自江南大学无锡医学院的Li‐Long Pan和江南大学食品科学与技术国家重点实验室的Wenying Niu、Xin Fang和Jia Sun*等人调查了丁酸梭菌菌株对急性胰腺...
CBM 588 于 1970 年被日本卫生和福利部批准用于人体临床。Miyarisan Pharmaceutical(日本东京)销售的标准制剂由白色标记的片剂组成,每片含有 0.35 × 10 6 个菌落形成单位(CFU ) C. butyricum MIYAIRI 588 (作为活性剂)。与其他口服益生菌一样,CBM 588 不会在肠道中永久存在。临床用CBM 588是通过深层厌氧发酵,...
Clostridioides difficile infection (CDI) represents the leading cause of nosocomial diarrhea worldwide and is associated with gut dysbiosis and intestinal damage. Clostridium butyricum MIYAIRI 588 (CBM 588) contributes significantly to reduce epithelial
Definition: Clostridium butyricum (CBM 588) is a Gram-positive, spore-forming, obligate anaerobic, non-pathogenic, non-genetically modified bacterium. Description: White or pale grey tablets with characteristic odour and sweet taste. Microbiological criteria:...
Clostridium butyricum M588- Miyarisan Pharmaceutical Alternative Names: Clostridium butyricum Miyairi 588 strain; C. butyricum CBM 588 Probiotic Strain; C. butyricum MIYAIRI Strain; C. butyricum Strain MIYAIRI 588; CBM-588; Cdactin-O; CM588; Miya-BM; MIYAIRI 588 Strain of C. butyricum Latest ...
and allowing the affected hamsters to consume orally Clostridium butyricum MIYAIRI 588 (hereinafter referred to briefly as "CbM"), one species of butyric acid bacteria by way of remedy. They have found the remedy to produce highly preferable results. This invention has been perfected as the resul...
AbstractBackground: Clostridium butyricum MIYAIRI (CBM) is a probiotic bacteria used for anti-diarrheal medicine in Japan. The preventive effect of CBM was investigated for antibiotic-associated diarrhea (AAD) in children.关键词: antibiotic-associated diarrhea Clostridium butyricum intestinal flora probiotic...